| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.30M | — |
| Operating expense | — | — |
| Net income | -31.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FATE returned +102.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +137.8% |
| 1 year | +102.6% |
| 5 years | -96.8% |
| 10 years | -10.4% |
| All-time high | $90.93 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FATE would be worth today ›No. Fate Therapeutics, Inc. has not paid a dividend in the past 12 months.
Fate Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol FATE.
Fate Therapeutics, Inc. is part of the Healthcare sector.
Fate Therapeutics, Inc. has a market cap of 279.18M USD, based on the latest quote.
Fate Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
